Bill Status of HB 4472   103rd General Assembly

Short Description:  HEALTH CARE AVAILABILITY

House Sponsors
Rep. Nabeela Syed-Emanuel "Chris" Welch-Lilian Jiménez, Laura Faver Dias, Kelly M. Cassidy, Anne Stava-Murray, Janet Yang Rohr, Abdelnasser Rashid, Katie Stuart, Kevin John Olickal, Will Guzzardi, Sharon Chung, Norma Hernandez, Matt Hanson, Theresa Mah, Maura Hirschauer, Diane Blair-Sherlock, Sue Scherer, Marcus C. Evans, Jr., Camille Y. Lilly, Sonya M. Harper, Jaime M. Andrade, Jr., Gregg Johnson, Elizabeth "Lisa" Hernandez, Kimberly Du Buclet, Suzanne M. Ness, Yolonda Morris and Mary Beth Canty

Last Action  View All Actions

DateChamber Action
  1/7/2025HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act
30 ILCS 105/5.1015 new

Synopsis As Introduced
Creates the Health Care Availability and Access Board Act. Establishes the Health Care Availability and Access Board to protect State residents, State and local governments, commercial health plans, health care providers, pharmacies licensed in the State, and other stakeholders within the health care system from the high costs of prescription drug products. Contains provisions concerning Board membership and terms; staff for the Board; Board meetings; circumstances under which Board members must recuse themselves; and other matters. Provides that the Board shall perform the following actions in open session: (i) deliberations on whether to subject a prescription drug product to a cost review; and (ii) any vote on whether to impose an upper payment limit on purchases, payments, and payor reimbursements of prescription drug products in the State. Permits the Board to adopt rules to implement the Act and to enter into a contract with a qualified, independent third party for any service necessary to carry out the powers and duties of the Board. Creates the Health Care Availability and Access Stakeholder Council to provide stakeholder input to assist the Board in making decisions as required by the Act. Contains provisions concerning Council membership, member terms, and other matters. Provides that the Board shall adopt the federal Medicare Maximum Fair Price as the upper payment limit for a prescription drug product intended for use by individuals in the State. Provides that the Attorney General shall have authority to enforce the Act and may pursue any available remedy under State law when enforcing the Act. Effective 180 days after becoming law.

Actions 
DateChamber Action
  1/17/2024HouseFiled with the Clerk by Rep. Nabeela Syed
  1/17/2024HouseAdded Chief Co-Sponsor Rep. Emanuel "Chris" Welch
  1/17/2024HouseFirst Reading
  1/17/2024HouseReferred to Rules Committee
  2/1/2024HouseAdded Co-Sponsor Rep. Laura Faver Dias
  2/2/2024HouseAdded Co-Sponsor Rep. Kelly M. Cassidy
  2/5/2024HouseAdded Co-Sponsor Rep. Anne Stava-Murray
  2/5/2024HouseAdded Co-Sponsor Rep. Janet Yang Rohr
  2/6/2024HouseAdded Co-Sponsor Rep. Abdelnasser Rashid
  2/6/2024HouseAdded Co-Sponsor Rep. Katie Stuart
  2/6/2024HouseAdded Co-Sponsor Rep. Kevin John Olickal
  2/7/2024HouseAdded Co-Sponsor Rep. Will Guzzardi
  2/7/2024HouseAdded Co-Sponsor Rep. Sharon Chung
  2/7/2024HouseAdded Co-Sponsor Rep. Norma Hernandez
  2/7/2024HouseAdded Co-Sponsor Rep. Matt Hanson
  2/7/2024HouseAdded Co-Sponsor Rep. Theresa Mah
  2/7/2024HouseAdded Co-Sponsor Rep. Maura Hirschauer
  2/8/2024HouseAdded Co-Sponsor Rep. Diane Blair-Sherlock
  2/8/2024HouseAdded Co-Sponsor Rep. Sue Scherer
  2/8/2024HouseAdded Co-Sponsor Rep. Marcus C. Evans, Jr.
  2/8/2024HouseAdded Co-Sponsor Rep. Camille Y. Lilly
  2/22/2024HouseAdded Co-Sponsor Rep. Sonya M. Harper
  2/22/2024HouseAdded Co-Sponsor Rep. Jaime M. Andrade, Jr.
  2/22/2024HouseAdded Co-Sponsor Rep. Gregg Johnson
  2/22/2024HouseAdded Co-Sponsor Rep. Yolonda Morris
  2/27/2024HouseAdded Co-Sponsor Rep. Elizabeth "Lisa" Hernandez
  2/28/2024HouseAssigned to Health Care Availability & Accessibility Committee
  2/28/2024HouseHouse Committee Amendment No. 1 Filed with Clerk by Rep. Nabeela Syed
  2/28/2024HouseHouse Committee Amendment No. 1 Referred to Rules Committee
  3/5/2024HouseHouse Committee Amendment No. 1 Rules Refers to Health Care Availability & Accessibility Committee
  3/5/2024HouseAdded Co-Sponsor Rep. Kimberly Du Buclet
  3/7/2024HouseHouse Committee Amendment No. 2 Filed with Clerk by Rep. Nabeela Syed
  3/7/2024HouseHouse Committee Amendment No. 2 Referred to Rules Committee
  3/7/2024HouseAdded Co-Sponsor Rep. Suzanne M. Ness
  3/12/2024HouseRemoved Co-Sponsor Rep. Yolonda Morris
  3/12/2024HouseAdded Co-Sponsor Rep. Yolonda Morris
  3/12/2024HouseHouse Committee Amendment No. 2 Rules Refers to Health Care Availability & Accessibility Committee
  4/5/2024HouseRule 19(a) / Re-referred to Rules Committee
  4/5/2024HouseHouse Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
  4/5/2024HouseHouse Committee Amendment No. 2 Rule 19(c) / Re-referred to Rules Committee
  4/5/2024HouseAdded Chief Co-Sponsor Rep. Lilian Jiménez
  10/9/2024HouseAdded Co-Sponsor Rep. Mary Beth Canty
  1/7/2025HouseSession Sine Die

Back To Top